Meenakshi Rao1, Daniella Rastelli2, Lauren Dong2, Sophia Chiu3, Wanda Setlik4, Michael D Gershon4, Gabriel Corfas5. 1. Department of Pediatrics, Columbia University Medical Center, New York, New York. Electronic address: mr3343@columbia.edu. 2. Department of Pediatrics, Columbia University Medical Center, New York, New York. 3. Institute of Human Nutrition, Columbia University, New York, New York. 4. Department of Pathology and Cell Biology, Columbia University, New York, New York. 5. Department of Otolaryngology-Head and Neck Surgery, Kresge Hearing Research Institute, Ann Arbor, Michigan.
Abstract
BACKGROUND & AIMS: When the glial fibrillary acidic protein (GFAP) promoter is used to express cellular toxins that eliminate glia in mice, intestinal epithelial permeability and proliferation increase; this led to the concept that glia are required for maintenance of the gastrointestinal epithelium. Many enteric glia, however, particularly in the mucosa, do not express GFAP. In contrast, virtually all enteric glia express proteolipid protein 1 (PLP1). We investigated whether elimination of PLP1-expressing cells compromises epithelial maintenance or gastrointestinal motility. METHODS: We generated mice that express tamoxifen-inducible Cre recombinase under control of the Plp1 promoter and carry the diptheria toxin subunit A (DTA) transgene in the Rosa26 locus (Plp1CreER;Rosa26DTA mice). In these mice, PLP1-expressing glia are selectively eliminated without affecting neighboring cells. We measured epithelial barrier function and gastrointestinal motility in these mice and littermate controls, and analyzed epithelial cell proliferation and ultrastructure from their intestinal tissues. To compare our findings with those from previous studies, we also eliminated glia with ganciclovir in GfapHSV-TK mice. RESULTS: Expression of DTA in PLP1-expressing cells selectively eliminated enteric glia from the small and large intestines, but caused no defects in epithelial proliferation, barrier integrity, or ultrastructure. In contrast, administration of ganciclovir to GfapHSV-TK mice eliminated fewer glia but caused considerable non-glial toxicity and epithelial cell death. Elimination of PLP1-expressing cells did not reduce survival of neurons in the intestine, but altered gastrointestinal motility in female, but not male, mice. CONCLUSIONS: Using the Plp1 promoter to selectively eliminate glia in mice, we found that enteric glia are not required for maintenance of the intestinal epithelium, but are required for regulation of intestinal motility in females. Previous observations supporting the concept that maintenance of the intestinal epithelium requires enteric glia can be attributed to non-glial toxicity in GfapHSV-TK mice and epithelial-cell expression of GFAP. Contrary to widespread notions, enteric glia are therefore not required for epithelial homeostasis. However, they regulate intestinal motility in a sex-dependent manner.
BACKGROUND & AIMS: When the glial fibrillary acidic protein (GFAP) promoter is used to express cellular toxins that eliminate glia in mice, intestinal epithelial permeability and proliferation increase; this led to the concept that glia are required for maintenance of the gastrointestinal epithelium. Many enteric glia, however, particularly in the mucosa, do not express GFAP. In contrast, virtually all enteric glia express proteolipid protein 1 (PLP1). We investigated whether elimination of PLP1-expressing cells compromises epithelial maintenance or gastrointestinal motility. METHODS: We generated mice that express tamoxifen-inducible Cre recombinase under control of the Plp1 promoter and carry the diptheria toxin subunit A (DTA) transgene in the Rosa26 locus (Plp1CreER;Rosa26DTAmice). In these mice, PLP1-expressing glia are selectively eliminated without affecting neighboring cells. We measured epithelial barrier function and gastrointestinal motility in these mice and littermate controls, and analyzed epithelial cell proliferation and ultrastructure from their intestinal tissues. To compare our findings with those from previous studies, we also eliminated glia with ganciclovir in GfapHSV-TK mice. RESULTS: Expression of DTA in PLP1-expressing cells selectively eliminated enteric glia from the small and large intestines, but caused no defects in epithelial proliferation, barrier integrity, or ultrastructure. In contrast, administration of ganciclovir to GfapHSV-TK mice eliminated fewer glia but caused considerable non-glial toxicity and epithelial cell death. Elimination of PLP1-expressing cells did not reduce survival of neurons in the intestine, but altered gastrointestinal motility in female, but not male, mice. CONCLUSIONS: Using the Plp1 promoter to selectively eliminate glia in mice, we found that enteric glia are not required for maintenance of the intestinal epithelium, but are required for regulation of intestinal motility in females. Previous observations supporting the concept that maintenance of the intestinal epithelium requires enteric glia can be attributed to non-glial toxicity in GfapHSV-TK mice and epithelial-cell expression of GFAP. Contrary to widespread notions, enteric glia are therefore not required for epithelial homeostasis. However, they regulate intestinal motility in a sex-dependent manner.
Authors: Yasmin Nasser; Ester Fernandez; Catherine M Keenan; Winnie Ho; Lorraine D Oland; Lee Anne Tibbles; Michael Schemann; Wallace K MacNaughton; Anne Rühl; Keith A Sharkey Journal: Am J Physiol Gastrointest Liver Physiol Date: 2006-06-22 Impact factor: 4.052
Authors: Jennifer L Zamanian; Lijun Xu; Lynette C Foo; Navid Nouri; Lu Zhou; Rona G Giffard; Ben A Barres Journal: J Neurosci Date: 2012-05-02 Impact factor: 6.167
Authors: Jonathon McClain; Vladimir Grubišić; David Fried; Roberto A Gomez-Suarez; Gina M Leinninger; Jean Sévigny; Vladimir Parpura; Brian D Gulbransen Journal: Gastroenterology Date: 2013-11-06 Impact factor: 22.682
Authors: Michael Meir; Natalie Burkard; Hanna Ungewiß; Markus Diefenbacher; Sven Flemming; Felix Kannapin; Christoph-Thomas Germer; Matthias Schweinlin; Marco Metzger; Jens Waschke; Nicolas Schlegel Journal: J Clin Invest Date: 2019-06-17 Impact factor: 14.808
Authors: Vladimir Grubišić; Alberto L Perez-Medina; David E Fried; Jean Sévigny; Simon C Robson; James J Galligan; Brian D Gulbransen Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-06-12 Impact factor: 4.052